Back to the main directory
Press Release
- Enefit Green sõlmis lepingu Tootsi tuulepargi arenduse omandamiseks by GlobeNewsWire
- BioXcel Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022 by GlobeNewsWire
- Mercury Marine Partners With Alliant Energy to Build Solar Array in Eastern Fond du Lac County by GlobeNewsWire
- Amicus Therapeutics to Announce Second Quarter 2022 Financial Results on August 4, 2022 by GlobeNewsWire
- Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022 by GlobeNewsWire
- Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA by GlobeNewsWire
- Microbix Presenting STI Multiplex Test Controls at AACC by GlobeNewsWire
- Blink Charging to Host Second Quarter 2022 Conference Call on Monday, August 8, 2022 by GlobeNewsWire
- Freight Technologies, Inc. Awarded Samsung Mexico SDS Contract by GlobeNewsWire
- Three Sweden Introduces Inseego 5G Routers for High-Speed Home Internet by BusinessWire
- PGTI Reports Record Second Quarter 2022 Results and Raises Full-Year 2022 Guidance by BusinessWire
- NEXGEL Launches MEDAGEL Hydroliner Pro Pads for Eyelash Protection During Cosmetic Extensions Service by GlobeNewsWire
- Enovix to Release Second Quarter 2022 Financial Results on August 10, 2022 by GlobeNewsWire
- FDA Accepts Biogen’s New Drug Application and Grants Priority Review of Tofersen for a Rare, Genetic Form of ALS by GlobeNewsWire
- OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven by GlobeNewsWire
- BridgeBio Pharma Announces Positive Interim Results from a Phase 2 Trial of Infigratinib in Achondroplasia Demonstrating an Increase in Annualized Height Velocity of 1.52 cm/year in Children 5 Years of Age and Older, and Adds 5th Cohort to Trial by GlobeNewsWire
- Reneo Pharmaceuticals Reports Positive Results from REN001 Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Study and Provides Additional Development Updates by GlobeNewsWire
- Brooklyn ImmunoTherapeutics Announces Results of Phase 2 Study of IRX-2 in Head and Neck Cancer by GlobeNewsWire
- Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation by GlobeNewsWire
- NIO to Hold Annual General Meeting and Class Meetings on August 25, 2022 by GlobeNewsWire
- First National Corporation Reports Second Quarter 2022 Financial Results by GlobeNewsWire
- Vivendi sponsor du Festival International du Film de La Biennale di Venezia et de Biennale College Cinema by BusinessWire
- Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s) by EQS Group AG
- COMPASS Pathways plc to announce second quarter 2022 financial results on 4 August 2022 by GlobeNewsWire
- Rubius Therapeutics to Announce Second Quarter 2022 Financial Results by GlobeNewsWire